The initial public offering of Tatva Chintan Pharma, a speciality chemical manufacturer, was concluded on Tuesday, 20 July 2021. It witnessed a mammoth 180.36 times subscription, which propelled it to become the second-most subscribed IPO in 2021, after MTAR technologies. Following an IPO’s closure, it takes about 6 days for the allotment to be finalised. …